HUM - Humana Inc.
NEXT EARNINGS:
Apr 29, 2026
EPS Est: $9.68
|
Rev Est: $38.5B
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$235.00
DETAILS
HIGH:
$345.00
LOW:
$146.00
MEDIAN:
$220.00
CONSENSUS:
$235.00
UPSIDE:
34.56%
Market Cap:
21.00B
Volume:
1,243,910
Avg Volume:
1,943,023
52 Week Range:
169.61-315.35
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Beta:
0.44
Last Dividend:
$3.54
Exchange:
NYSE
Country:
US
Employees:
65,680
IPO Date:
1981-12-31
EPS (TTM):
9.87
P/E Ratio:
25.97
Revenue (TTM):
129.66B
Total Assets:
48.91B
Total Debt:
12.37B
Cash & Equiv:
4.20B
Rev Growth (5Y):
10.9%
EPS Growth (5Y):
-17.3%
FCF Growth (5Y):
-39.6%
ROCE:
6.4%
Debt/Equity:
0.70
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-02-11 | $-3.96 | $-4.01 | +1.2% | $32.5B | $35.6B | -8.7% |
| 2025-11-05 | $3.24 | $2.93 | +10.6% | $32.6B | $32.0B | +2.0% |
| 2025-07-30 | $6.27 | $5.92 | +5.9% | $32.4B | $31.9B | +1.6% |
| 2025-04-30 | $11.58 | $10.07 | +15.0% | $32.1B | $32.2B | -0.3% |
| 2025-02-11 | $-2.16 | $-2.23 | +3.1% | $29.2B | $28.8B | +1.4% |
| 2024-10-30 | $4.16 | $3.40 | +22.4% | $29.4B | $28.7B | +2.5% |
| 2024-07-31 | $6.96 | $5.85 | +19.0% | $29.5B | $28.5B | +3.6% |
| 2024-04-24 | $7.23 | $6.12 | +18.1% | $29.6B | $28.5B | +3.8% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 129.66B | 117.76B | 106.37B | 92.87B | 83.06B | 77.16B | 64.89B | 56.91B | 53.77B | 54.38B | 54.29B | 48.50B |
| Net Income | 1.19B | 1.21B | 2.49B | 2.81B | 2.93B | 3.37B | 2.71B | 1.68B | 2.45B | 614.00M | 1.28B | 1.15B |
| EPS | 9.87 | 10.01 | 20.09 | 22.20 | 22.79 | 25.47 | 20.19 | 12.24 | 16.94 | 4.11 | 8.54 | 7.44 |
| Total Assets | 48.91B | 46.48B | 47.06B | 43.05B | 44.36B | 34.97B | 29.07B | 25.41B | 27.18B | 25.40B | 24.68B | 23.53B |
| Total Debt | 12.37B | 11.14B | 10.21B | 9.03B | 10.54B | 6.06B | 4.97B | 4.38B | 4.77B | 3.79B | 3.79B | 3.83B |
| Cash & Equivalents | 4.20B | 2.22B | 4.69B | 5.06B | 3.39B | 4.67B | 4.05B | 2.34B | 4.04B | 3.88B | 2.57B | 1.94B |
| Operating Cash Flow | 921.00M | 2.97B | 3.98B | 4.59B | 2.26B | 5.64B | 5.28B | 2.17B | 4.05B | 1.94B | 868.00M | 1.62B |
| Free Cash Flow | 375.00M | 2.39B | 2.98B | 3.45B | 920.00M | 4.67B | 4.55B | 1.56B | 3.52B | 1.41B | 345.00M | 1.09B |
| FCF per Share | 3.11 | 19.83 | 24.03 | 27.29 | 7.15 | 35.36 | 33.93 | 11.35 | 24.40 | 9.43 | 2.31 | 7.07 |
| Book Value | 17.66B | 16.38B | 16.26B | 15.31B | 16.08B | 13.73B | 12.04B | 10.16B | 9.84B | 10.69B | 10.35B | 9.65B |
| Cash & ST Investments | 19.90B | 2.22B | 4.69B | 5.06B | 3.39B | 4.67B | 15.03B | 2.34B | 4.04B | 3.88B | 2.57B | 1.94B |
| ROC Equity | 0.07 | 0.07 | 0.15 | 0.18 | 0.18 | 0.25 | 0.22 | 0.17 | 0.25 | 0.06 | 0.12 | 0.12 |